معرفی
Gustav Torisson serves as Associate Professor and Postdoctoral Fellow at Lund University's Faculty of Medicine, with affiliations spanning Clinical Infection Medicine, MultiPark (Multidisciplinary Research on Parkinson's Disease), Cognitive Disorders, and Infect@LU. His work directly supports UN Sustainable Development Goal 3 (Good Health and Well-being) through clinical infection research and neurodegenerative disease studies.
Research focuses on infectious disease mechanisms and treatment optimization, particularly bloodstream infections, sepsis, antimicrobial resistance, and community-acquired pneumonia. His epidemiological approach integrates population-based cohort studies with clinical pharmacology, examining disease severity markers and antibiotic efficacy. Neurodegenerative connections are explored through MultiPark collaborations, investigating infection-cognition links in Parkinson's disease.
Recent publications (2024-2025) reveal three critical trends: precision antimicrobial dosing using minimum inhibitory concentrations for Gram-negative infections, shock management innovations with norepinephrine via midline catheters, and disease severity predictors like time-to-positivity in bacteremia. These studies consistently employ robust epidemiological designs while addressing urgent clinical challenges in aging populations.
Torisson actively supervises 4 graduate works and leads the Maggie Stephens stiftelse-funded project "Improved treatment of serious infections in an aging population" (2024-2026). He also contributes to the dissertation project "Antimicrobial resistance and sepsis" under Kristian Riesbeck's supervision. His research attracts significant attention, with coverage in news outlets, 16+ X posts, and 17 Mendeley readers.
As core faculty in Infect@LU and MultiPark, he bridges clinical infection medicine with neurodegenerative research through multidisciplinary teams. Current work emphasizes real-world treatment protocols for vulnerable elderly patients, with future directions targeting antimicrobial stewardship in aging populations and infection-related cognitive decline mechanisms.
